BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15239337)

  • 1. [Cyclooxygenase 2 and breast cancer. From biological concepts to therapeutic trials].
    Guastalla JP; Bachelot T; Ray-Coquard I
    Bull Cancer; 2004 May; 91 Spec No():S99-108. PubMed ID: 15239337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cyclooxygenase 2 and breast cancer. From biological concepts to clinical trials].
    Guastalla JP; Bachelot T; Ray-Coquard I
    Bull Cancer; 2004 May; 91 Suppl 2():S99-108. PubMed ID: 15899633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma (Review).
    Badawi AF; Badr MZ
    Int J Oncol; 2002 Jun; 20(6):1109-22. PubMed ID: 12011987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cyclooxygenase 2 inhibitors and lung carcinoma].
    Spano JP; Chouahnia K; Morère JF
    Bull Cancer; 2004 May; 91 Spec No():S109-12. PubMed ID: 15239338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention.
    Kismet K; Akay MT; Abbasoglu O; Ercan A
    Cancer Detect Prev; 2004; 28(2):127-42. PubMed ID: 15068837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer.
    Howe LR; Subbaramaiah K; Patel J; Masferrer JL; Deora A; Hudis C; Thaler HT; Muller WJ; Du B; Brown AM; Dannenberg AJ
    Cancer Res; 2002 Oct; 62(19):5405-7. PubMed ID: 12359744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cyclooxygenase 2 inhibitors and lung carcinoma].
    Spano JP; Chouahnia K; Morère JF
    Bull Cancer; 2004 May; 91 Suppl 2():S109-12. PubMed ID: 15899634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of COX-2 inhibition in breast cancer treatment and prevention.
    Arun B; Goss P
    Semin Oncol; 2004 Apr; 31(2 Suppl 7):22-9. PubMed ID: 15179621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyclooxygenase 2 inhibitors and urologic and gynaecologic cancers].
    Eschwege P
    Bull Cancer; 2004 May; 91 Spec No():S113-6. PubMed ID: 15239339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.
    Harris RE; Alshafie GA; Abou-Issa H; Seibert K
    Cancer Res; 2000 Apr; 60(8):2101-3. PubMed ID: 10786667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer.
    Liao Z; Milas L; Komaki R; Stevens C; Cox JD
    Am J Clin Oncol; 2003 Aug; 26(4):S85-91. PubMed ID: 12902863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
    Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Researchers plan to continue to study COX-2 inhibitors in cancer treatment and prevention.
    Vanchieri C
    J Natl Cancer Inst; 2005 Apr; 97(8):552-3. PubMed ID: 15840872
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?
    Koga H
    Cancer; 2003 Aug; 98(4):661-7. PubMed ID: 12910508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2: a potential target in breast cancer.
    Wang D; Dubois RN
    Semin Oncol; 2004 Feb; 31(1 Suppl 3):64-73. PubMed ID: 15052544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NSAIDs and breast cancer: a possible prevention and treatment strategy.
    Agrawal A; Fentiman IS
    Int J Clin Pract; 2008 Mar; 62(3):444-9. PubMed ID: 18194278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].
    Florent C; Meary N
    Bull Cancer; 2004 May; 91 Spec No():S85-8. PubMed ID: 15239335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
    Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L
    Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cyclooxygenase 2 inhibitors and cancer chemoprevention].
    Masmoudi A; Chevalier TL; Sabatier L; Soria JC
    Bull Cancer; 2004 May; 91 Suppl 2():S77-84. PubMed ID: 15899630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention.
    Chun KS; Surh YJ
    Biochem Pharmacol; 2004 Sep; 68(6):1089-100. PubMed ID: 15313405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.